Biography
Dr. Damon Tojjar
Physician-scientist (M.D., Ph.D. candidate) and digital health entrepreneur in diabetes research, clinical medicine, and AI-driven care.
- M.D.Lund University
- StanfordSystems Medicine
- ScienceMagnus Blix Award
- EITTop 20 Deep Tech
Biography
A clinician and a scientist.
Dr. Damon Tojjar is a physician-scientist and digital health entrepreneur. He earned his M.D. at Lund University and is a Ph.D. candidate in medical science at the Lund University Diabetes Centre, with research on the genetics of type 2 diabetes, and he trained as a Research Fellow in Systems Medicine at Stanford University School of Medicine under Professor Atul Butte.
His work spans global drug development, clinical AI and decision support, medical-device regulation, and the critical appraisal of clinical evidence across medicine. He co-developed EASY Diabetes, an AI clinical decision-support system evaluated in the EASY-1 randomized controlled trial (Medtech4Health Innovation Award), and co-founded Vi-Health, named an EIT Top 20 Deep Tech company and acquired by Numan. He mentors early-career founders and scientists, including with UCLA Ventures and the Nucleate program, and has served as a board member of Lund University's innovation and holding companies, LU Innovation (now LU Ventures) and LU Holding.
His peer-reviewed work appears under the name Tojjar, D., including a Science paper recognized with the Magnus Blix Award and a Diabetes Care meta-analysis cited more than 800 times. He explains and evaluates medical evidence as a reference voice and does not provide medical care.
At a glance
The essentials.
Frequently asked
About Dr. Tojjar.
Who is Dr. Damon Tojjar?
A physician-scientist (M.D., Ph.D. candidate) and digital health entrepreneur whose work spans drug development, clinical AI and decision support, medical-device regulation, and the critical appraisal of clinical evidence across medicine.
What is he known for?
Co-developing EASY Diabetes, an AI clinical decision-support system evaluated in the EASY-1 randomized controlled trial, and co-founding Vi-Health, a Top 20 Deep Tech finalist in the EIT Digital Challenge, acquired by Numan; plus peer-reviewed diabetes-genetics research.
How is his name cited in academic work?
Under the publication name Tojjar, D., in Science, Diabetes Care, Diabetologia, and Diabetes, Obesity and Metabolism.
How can I reach him?
Through the contact address on this page. His fully sourced verified record is at damontojjar.com/record.
Contact
Get in touch.
For collaboration, advisory, speaking, or media, reach out directly.